These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19528520)

  • 1. The risks and costs of multiple-generic substitution of topiramate.
    Duh MS; Paradis PE; Latrémouille-Viau D; Greenberg PE; Lee SP; Durkin MB; Wan GJ; Rupnow MF; LeLorier J
    Neurology; 2009 Jun; 72(24):2122-9. PubMed ID: 19528520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries.
    Paradis PE; Latrémouille-Viau D; Moore Y; Mishagina N; Lafeuille MH; Lefebvre P; Gaudig M; Duh MS
    Curr Med Res Opin; 2009 Jul; 25(7):1793-805. PubMed ID: 19505202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
    LeLorier J; Duh MS; Paradis PE; Lefebvre P; Weiner J; Manjunath R; Sheehy O
    Neurology; 2008 May; 70(22 Pt 2):2179-86. PubMed ID: 18505997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
    Erickson SC; Le L; Ramsey SD; Solow BK; Zakharyan A; Stockl KM; Harada AS; Curtis B
    Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.
    Kwong WJ; Kamat S; Fang C
    Ann Pharmacother; 2012 Dec; 46(12):1609-16. PubMed ID: 23150608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine.
    Duh MS; Andermann F; Paradis PE; Weiner J; Manjunath R; Crémieux PY
    Dis Manag; 2007 Aug; 10(4):216-25. PubMed ID: 17718660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden associated with the use of generic antiepileptic drugs in the United States.
    Helmers SL; Paradis PE; Manjunath R; Duh MS; Lafeuille MH; Latrémouille-Viau D; Lefebvre P; Labiner DM
    Epilepsy Behav; 2010 Aug; 18(4):437-44. PubMed ID: 20580619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
    Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
    Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brand versus generic alendronate: gastrointestinal effects measured by resource utilization.
    Halkin H; Dushenat M; Silverman B; Shalev V; Loebstein R; Lomnicky Y; Friedman N
    Ann Pharmacother; 2007 Jan; 41(1):29-34. PubMed ID: 17190847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization.
    Manjunath R; Paradis PE; Parisé H; Lafeuille MH; Bowers B; Duh MS; Lefebvre P; Faught E
    Neurology; 2012 Oct; 79(18):1908-16. PubMed ID: 23077014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
    Andermann F; Duh MS; Gosselin A; Paradis PE
    Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risks and costs of multiple-generic substitution of topiramate.
    Sethi NK; Torgovnick J; Sethi PK; Arsura E; Emmanuel Paradis P; Duh MS; Durkin MB; Wan GJ
    Neurology; 2010 Feb; 74(8):701-2; author reply 701-2. PubMed ID: 20177127
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs.
    Hansen RA; Qian J; Berg R; Linneman J; Seoane-Vazquez E; Dutcher SK; Raofi S; Page CD; Peissig P
    Pharmacotherapy; 2017 Apr; 37(4):429-437. PubMed ID: 28152215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic antiepileptic drugs and associated medical resource utilization in the United States.
    Labiner DM; Paradis PE; Manjunath R; Duh MS; Lafeuille MH; Latrémouille-Viau D; Lefebvre P; Helmers SL
    Neurology; 2010 May; 74(20):1566-74. PubMed ID: 20393142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antiepileptic drug substitutions on epileptic events requiring acute care.
    Rascati KL; Richards KM; Johnsrud MT; Mann TA
    Pharmacotherapy; 2009 Jul; 29(7):769-74. PubMed ID: 19558250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
    Davis KL; Candrilli SD; Edin HM
    Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
    Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
    Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
    Contin M; Alberghini L; Candela C; Benini G; Riva R
    Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting.
    LeLorier J; Duh MS; Paradis PE; Latrémouille-Viau D; Lefebvre P; Manjunath R; Sheehy O
    Curr Med Res Opin; 2008 Apr; 24(4):1069-81. PubMed ID: 18315941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic substitution of antiepileptic drugs.
    Sander JW; Ryvlin P; Stefan H; Booth DR; Bauer J
    Expert Rev Neurother; 2010 Dec; 10(12):1887-98. PubMed ID: 21091318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.